Skip to main content
. 2022 Oct 19;2022:9004830. doi: 10.1155/2022/9004830

Figure 8.

Figure 8

The expression of cuproptosis-related prognostic signature in various groups of patients with breast cancer. The expression of CDKN2A (a), MTF1 (b), PDHA1 (c), DLD (d), LIPT1 (e), and FDX1 (f) in breast cancer patients in different pTNM stages.